I
n Canada (as elsewhere) there is a growing demand for human eggs for reproductive purposes 1 and currently demand exceeds supply. This is not surprising, as egg production and retrieval is onerous. It requires considerable time, effort, and energy and carries with it significant physical and psychological risks. 2 In very general terms, one cycle of egg production and retrieval involves an estimated total of 56 hours for interviews, counseling, and medical procedures 3 (i.e., screening, hormonal stimulation, and egg retrieval). The screening carries risks of unanticipated findings with severe consequences for insurability (which can be catastrophic). 4 The daily hormone injections can be painful and uncomfortable, causing cramping, abdominal pain, nausea, vomiting, bloating, mood changes, and irritability. More serious potential harms include rapid weight gain and respiratory difficulty, damage to the organs that are close to the ovaries (e.g., bladder, bowel, uterus), decreased fertility, infertility, and life-threatening hemorrhage, thromboembolism, and ovarian, breast, or colon cancer. 5 Potential psychological harms include significant stress and its sequelae. 6 It is one thing to incur these physical and psychological risks in pursuit of a personal reproductive project; it is quite another to do so for someone else's reproductive project. Indeed, given the time, inconvenience, and risks involved (of which we have listed but a few illustrative examples), few women are sufficiently motivated by altruism alone to provide eggs for others. 7 Some women are willing to do so for financial benefit -but this is not a legal option in Canada, as payment for eggs is prohibited. Furthermore, reimbursement of expenses is restricted. 8 Other jurisdictions do not prohibit the sale of human eggs, 9 or they claim to prohibit the sale of human eggs but permit compensation well above the reimbursement of actual expenditures. 10 Within this context of inconsistent regulatory frameworks, a global market for human eggs has emerged. 11 Not surprisingly, Canadians have been targeted as potential providers and recipients. What is surprising, however -given the legal prohibition on payment for human eggs and the constraints on reimbursement -is the active participation of Canadians in the transnational human egg trade. 12 More surprising still is the apparent failure of Canadian authorities to properly respond. 13 
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In this paper, we first provide as accurate a picture as possible of transnational trade in human eggs involving Canadians (as providers, recipients, intermediaries or health care professionals). Second, we explain the legal status in Canada of trade in human eggs as it has evolved since 2004. Finally, we reflect on what Canadian authorities should do with respect to this transnational trade. This project is obviously significant for Canada as it relates to the conduct of Canadians in an area the federal government decided warranted very serious legislative intervention. However, it is also significant for other jurisdictions for at least two reasons: first, because when Canadians participate in the transnational human egg trade and Canadian authorities regulate transnational trade, individuals and organizations in other countries are also affected as providers, recipients, or intermediaries; and second, because some of the arguments that we make about the application of Canadian domestic law to conduct engaged in outside of Canada may be adaptable to other jurisdictions with sufficiently similar legal regimes.
Before proceeding further, we must define key terms and delineate the scope of the paper. In this paper, "trade" refers to the buying and selling of goods and services. "Providers" refers to the women who provide eggs for payment or as a gift. "Recipients" refers to both the women and men who receive eggs for reproductive use. The terms "providers" and "recipients" do not import assumptions about the nature of any transaction the parties engage in -whether commercial or altruistic. We do not use the terms "donor," "donor eggs," or "donation," as these terms mask the financial nature of certain transactions and trade on the traditional ideals of femininity -selfless, caring, nurturing, and devoted to helping others have families. 14 "Intermediary" refers to an individual (e.g., broker, concierge, or consultant) or an organization (e.g., fertility clinic or egg bank) that arranges or negotiates, in whole or in part, a transaction between providers and recipients. For the purposes of this paper, we restrict our scope to federal domestic legislation 15 relating to commercial transactions that involve one or more aspects of egg production and collection (i.e., screening, hormonal stimulation, and egg retrieval) for reproductive purposes and that happen in Canada and/or involve Canadians.
Transnational Trade in Human Eggs
In the past couple of years, a number of studies have been published on transnational trade in reproductive tissues and services. 16 Nonetheless, there is very little data on this evolving practice in Canada, and there is good reason to be concerned about the quality of what little data there is. 17 That said, on the basis of the best available evidence (which includes empirical work, reports from investigative journalists, and information posted on intermediaries' websites), 18 we know that Canadians are going abroad to get human eggs, foreign nationals are coming to Canada to provide human eggs, and Canadians are importing human eggs from abroad (i.e., without going abroad themselves). Moreover, we know that the following financial transactions are taking place: payment for human eggs; 19 payment for services in connection with the provision of human eggs; and reimbursement (both per se and above expenditures, 20 and both with and without receipts). What we do not know is how many Canadians are involved in such transactions, whether the practice is growing and, if so, at what rate. The paucity of Canadian data reflects both inadequate regulation of assisted human reproduction in Canada and the underground nature of the evolving practice (as a consequence of which, individuals participating in transnational trade may be reluctant to participate in research studies needed to generate reliable data).
In this paper, we first provide as accurate a picture as possible of transnational trade in human eggs involving Canadians (as providers, recipients, intermediaries or health care professionals 23 The survey was posted on the websites of three patient organizations, one in Australia and two in Canada. There were 95 usable responses, of which 28 were from individuals who had participated in transnational travel for reproductive services. The most common reason given for transnational travel was availability of eggs and sperm (75%). Fifteen of the 28 patients (54%) had gone abroad to get eggs and two of the 28 patients (7%) had gone abroad for both eggs and sperm. Of the 28 who had participated in transnational travel, 21 provided information about their country of residence and 13 of these were Canadian. The destination countries for Canadians seeking eggs were India, Mexico, and the USA, and for combined eggs and sperm, the destination country was the Czech Republic.
Hughes and DeJean conducted a mail and online survey of Canadian and American fertility clinics. 24 There were 28 responses from 34 Canadian clinics, a response rate of 82%. The most common reason given for transnational travel (80%) was access to anonymous eggs. In response to the survey question, "How many patients per year does your clinic send out of country for ART services?", 59% of respondents provided estimates and 41% provided formal data. The aggregate response, as reported by the authors, is that 365 patients per year went abroad for anonymous eggs -277 to the United States, 54 to Latin America, 1 to Europe, 2 to India/Asia, and 29 elsewhere. As well, 2 patients travelled to the US and 2 more to India for eggs from known providers. In the American part of the study, 125 responses were received from a total of 392 Society for Assisted Reproductive Technologies registered clinics, a response rate of 32%. In answer to the survey question, "How many patients per year does your clinic receive from outside of the United States for the fol- 25 These data, while neither extensive nor robust, all support the conclusion that Canadians are going abroad to purchase human eggs.
Foreign Nationals Coming to Canada to Provide and Receive Human Eggs
The Blyth study (cited above) reported on one American egg provider travelling to Canada from the United States. 26 The Hughes and DeJean study (also cited above) reported on four persons being sent by American clinics to Canada to get anonymous eggs. 27 Alison Motluk, an investigative journalist, has also reported on the U.S. 29 [A] young woman named Sonja, who lives in Washington State, chronicles in detail her six egg donations, all in Canada, between March 2007 and June 2009.…Each time,…she got to name her compensation, which started at $3,000 and rose to $6,000 by the end. 30 Another option which takes advantage of the open market for eggs in parts of the United States, has also gained favour. Instead of finding donors through Canadian clinics, many parents work with US-based agencies, which match them up with young women -mostly American but some Canadian -who fly in days before the retrieval, their ovaries already ripe with eggs. 31 While anecdotal, these data are not inconsequential. Clearly, foreign nationals are coming to Canada to both provide and receive human eggs.
Canadians Importing Frozen Human Eggs
While considered experimental for a number of years, in 2012, the Practice Committee of the American Society for Reproductive Medicine issued a report which concluded that oocyte cryopreservation "should no longer be considered experimental." 32 Human egg freezing is now widely available and, in experienced labs, 70-90% of eggs survive the freeze-thaw process. 33 Egg freezing technology has expanded the global market in human eggs, which no longer need involve the cross-border movement of providers or recipients for the exchange of fresh human eggs. Instead, it is now possible, and eventually may be preferable, for frozen eggs to travel "alone" across borders. In a recent series of stories about the human egg trade, CBC News reported on the numbers of transnational egg transactions. According to Diana Thomas, president of the World Egg Bank in Phoenix:
We did about 100 eggs to Canada in the last six months…When I speak to doctors individually they really have no fear about the [Canadian] legislation. They just don't want to all of sudden be used as a test case when it hits the press. 34 A related news report included an interview with Dr. Matt Gysler at the ISIS Regional Fertility Centre in Oakville, Ontario, who said he "has a dozen pregnancies underway using frozen eggs from the U.S." 35 These comments provide confirmation from both sides of the border that frozen eggs are being imported into Canada.
Canadian Law on Transnational Trade in Human Eggs
Canadian law relevant to trade in human eggs can be found in the Assisted Human Reproduction Act of 2004 as amended in 2012 (hereafter AHR Act), 36 and the 2010 Supreme Court of Canada's (SCC) Reference re Assisted Human Reproduction Act (hereafter AHRA Reference). 37 In brief, s. 7 of the AHR Act unquestionably prohibits purchasing, offering to purchase, and advertising for the purchase of eggs and, arguably, also prohibits purchasing, offering to purchase, and advertising for the purchase of egg production services. Section 8 prohibits the use of eggs for the purpose of creating an embryo unless the egg provider has given written consent in accordance with the regulations to its use for that purpose (the section and its regulations having come into force December 1, 2007). Section 10
(not yet in force) will prohibit the distribution, making use of, or importation of eggs for the purpose of reproduction unless various health and safety conditions as set out in regulations (not yet drafted) are met. Section 12 (not yet in force) will permit reimbursement of receipted expenditures if done in accordance with the regulations (not yet drafted).
The law with respect to transnational trade in human eggs can be found in the AHR Act itself as well as the law governing the application of Canadian laws to conduct engaged in, in whole or in part, in other countries. When all of the prohibited activities associated with the transnational trade in eggs take place in Canada, then the AHR Act applies directly (e.g., the egg provider comes to Canada for the egg retrieval). When the activities take place in whole or in part outside Canada (e.g., the egg retrieval happens in India), the AHR Act may nonetheless apply through the "qualified territorial application" of law where what is known as the Libman test is met.
Each of these areas of law is explained in greater detail below.
Purchasing, Offering to Purchase, Advertising for the Purchase Section 7(1) of the AHR Act stipulates: "No person shall purchase, offer to purchase or advertise for the purchase of sperm or ova from a donor or a person acting on behalf of a donor." Section 7 came into force April 22, 2004 . Upon conviction, under ss. 60 and 62, these activities are punishable by a fine of up to $500,000 or imprisonment up to ten years or both, forfeiture and disposition of material or information by means of which the offence was committed, and an order not to engage in activity that might lead to the commission of an offence under the AHR Act.
Beyond the explicit prohibition on purchasing, offering to purchase, and advertising for the purchase of eggs, it can be argued that s. 7 also prohibits these same activities in relation to third party egg production services. In the AHRA Reference, Justice Cromwell characterized s. 12, which concerns reimbursement of expenditures incurred in the course of providing eggs, as carving out an exemption to, and defining the scope of, s. 7. 38 This logically means that without s. 12, reimbursement of receipted expenditures is captured under s. 7 and not permitted under the AHR Act. If, without s. 12, reimbursement of receipted expenditures constitutes "purchasing ova," then it can be argued that, anything similarly related to purchasing ova but not explicitly exempted under s. 12 (such as the purchase of egg production services) constitutes "purchasing ova." On this basis, it can be argued that s. 7 of the AHR Act which prohibits purchasing, offering to purchase, and advertising for the purchase of eggs includes within its ambit egg production services.
This analysis notwithstanding, the conclusion is not incontrovertible. The other judges in the AHRA Reference did not describe the relationship between ss. 7 and 12 in the same way as Justice Cromwell. Rather, the four justices with whom he sided in upholding s. 12 characterized s. 12 as itself a prohibition subject to its own exceptions. 39 That said, the only way that s.
12 survived the constitutional challenge was through Justice Cromwell's conclusion that it was constitutionally valid and his conclusion about constitutionality hinged on his characterization of s. 12 as an exemption to s. 7. Thus, one can go as far as, albeit no further than, saying it can be argued that s. 7 prohibits both purchasing, offering to purchase, and advertising for the purchase of eggs and egg production services.
Consent
Section 8(1) of the AHR Act stipulates: "No person shall make use of human reproductive material for the purpose of creating an embryo unless the donor of the material has given written consent, in accordance with the regulations, to its use for that purpose." Section 8 came into force December 1, 2007 concurrent with the coming into force of the s. 8 regulations. 40 Upon conviction, under ss. 61 and 62, a violation of s. 8 is punishable by a fine of up to $250,000 or imprisonment up to five years or both, forfeiture and disposition of material or information by means of which the offence was committed, and an order not to engage in activity that might lead to the commission of an offence under the AHR Act. 41 Distribution, Making Use, and Importation Section 10 of the AHR Act, as amended in 2012 (but not yet in force), 42 stipulates:
(1) The purpose of this section is to reduce the risks to human health and safety arising from the use of sperm or ova for the purpose of assisted human reproduction, including the risk of the transmission of disease.
(2) Subject to subsection (3), no person shall distribute, make use of or import any of the following for the purpose of assisted human reproduction: … (b) an ovum that has been obtained from a donor and that is meant for the use of a female person other than a spouse, common-law partner or sexual partner of the donor; (c) an ovum that has been obtained from a donor and that is meant for the donor's use as a surrogate mother.
(3) Subsection (2) does not apply if (a) tests have been conducted in respect of the…ovum in accordance with the regulations, and the…ovum has been obtained, prepared, preserved, quarantined, identified, labelled and stored and its quality assessed in accordance with the regulations; and (b) the donor of the…ovum has been screened and tested, and the donor's suitability has been assessed, in accordance with the regulations.
(4) No person shall, except in accordance with the regulations, engage in any activity described in paragraph (3)(a) or (b) in respect of any of the following with the intention of distributing or making use of it for the purpose of assisted human reproduction: … (b) an ovum described in paragraph (2)(b); or (c) an ovum described in paragraph (2)(c).
The original s. 10 came into force on April 22, 2004 . This section was among those found to be unconstitutional in the AHRA Reference. It has since been revised and now includes an explicit statement of purpose ("to reduce the risks to human health and safety,…includ-ing the risk of transmission of disease") and contains specific limits on the distribution, use, and importation of eggs with significant potential implications for transnational trade in human eggs. Most significantly, it states: "no person shall distribute, make use of or import… for the purposes of human reproduction… an ovum that has been obtained from a donor and that is meant for the use of a female person other than a spouse, common-law partner or sexual partner of the donor" unless "tests have been conducted", the "ovum has been obtained, prepared, preserved, quarantined, identified, labeled and stored and its quality assessed", and the donor of the ovum "has been screened and tested", all in accordance with the regulations. As noted above, s. 10 is not yet in force and no regulations have yet been made. Once the section is in force and
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regulations have been made, the distribution, making use, or importation of fresh eggs for reproductive purposes will be limited to those who are the spouse, common-law partner or sexual partner of the providers (as it is not possible to quarantine fresh eggs and still have them be useable). In effect, the distribution, making use, or importation of eggs for reproductive purposes will be limited to frozen eggs from sources and through processes that can meet the health and safety requirements. Upon conviction, under ss. 61 and 62, a violation of s. 10 will be punishable by a fine of up to $250,000 or imprisonment up to five years or both, forfeiture and disposition of material or information by means of which the offence was committed, and an order not to engage in activity that might lead to the commission of an offence under the AHR Act.
Reimbursement
Section 12(1) of the AHR Act stipulates that: "No person shall, except in accordance with the regulations (a) reimburse a donor for an expenditure incurred in the course of donating sperm or an ovum;... (2) No person shall reimburse an expenditure referred to in subsection (1) unless a receipt is provided to that person for the expenditure." Upon conviction, under ss. 61 and 62, the activity will be punishable by a fine of up to $250,000 or imprisonment up to five years or both, forfeiture and disposition of material or information by means of which the offence was committed, and an order not to engage in activity that might lead to the commission of an offence under the AHR Act.
At the time of writing, no regulations have been made under this section of the AHR Act and s. 12 is not yet in force. In the absence of regulations for s. 12, there has been debate about the scope of legitimate payments for reimbursable expenses. It has been suggested (and it seems to have occurred in some circumstances) that "reimbursements" can include compensation for the labour involved in providing eggs (which is sometimes referred to as the time, inconvenience and discomfort involved in egg production). 43 However, we would argue that s. 12 will only permit a narrower range of payments. In support of this claim, we note that while reimbursement for receipted expenditures is explicitly set out for eggs and for contract pregnancy (i.e., surrogacy), reimbursement for loss of work-related income is only explicitly set out for surrogacy. 44 It follows that one should interpret the AHR Act as not permitting reimbursement for loss of workrelated income for egg providers.
The absence of regulations for s. 12, and the fact that s. 12 is not yet in force, also raise a question about the current legal status of reimbursements (with or without receipts). Health Canada and AHRC have stated 45 (and others have repeated the claim 46 ) that, under the AHR Act with s.
12 not yet in force, reimbursement is permitted in Canada. In our view, however, this is not a compelling interpretation of the law. If reimbursement is an exemption to the s. 7 prohibition (as described by Justice Cromwell) then, arguably, the exemption does not come into force until the section is in force. In other words, if s. 12 "defines the scope of the prohibitions", then the scope of s. 7 is not limited until s. 12 is in force -meaning all payments (including reimbursements of receipted expenditures) are prohibited until that time. As before, it must be noted here that Justice Cromwell was writing for himself alone. However, again as before, the constitutionality of s. 12 hinged on Justice Cromwell and his finding of constitutionality hinged on this characterization of s. 12. That said, one can go as far as, albeit no further than, saying it can be argued that reimbursement is not permitted under the AHR Act until s. 12 and its regulations come into force.
It should also be noted here that AHRC has stated that "[d]onors, those maintaining and transporting in vitro embryos, and surrogate mothers are currently allowed to be reimbursed for actual expenses they may incur." 47 However, this statement is incomprehensible. If it is assumed that reimbursements are permitted because s. 12 is not yet in force (as AHRC is assuming), then how can there be any restrictions on reimbursements (i.e., how can they be limited to "actual expenses they may incur")?
Transnational Application of Canadian Law
The AHR Act clearly regulates transnational trade in human eggs. First, inasmuch as all (or almost all) of the activities associated with the trade in human eggs take place in Canada, the AHR Act applies directly. That is, ss. 7 and 8 (and ss. 10 and 12 once in force) of the law apply incontrovertibly where a provider comes to Canada from another country for egg retrieval, the eggs are provided to a person in Canada, and payment is made to the provider or an intermediary in Canada. Second, s. 8 governs the use of sperm, eggs, and embryos in Canada "regardless of where the material or in vitro embryos were originally obtained." 48 Third, s. 10 addresses the importation of eggs -clearly contemplating transnational activity -and, so, once in force, will expand the scope of regulated activities.
Beyond this, it is possible for Canadian law to apply to conduct engaged in, in part or in whole, outside of Canada. One path to the application of laws beyond Canada's borders is through an explicit statement in the legislation that the laws are intended to apply even where the conduct takes place abroad. This has been done, for example, through the Criminal Code to combat child sex tourism 49 and human trafficking. 50 However, there are no provisions in the AHR Act to establish extraterritorial application of any part of the AHR Act. Therefore, if all aspects of the trade in human eggs take place entirely in another country, Canadian authorities cannot intervene.
However, this is not the end of the story, as there is another path to the application of Canadian laws beyond Canada's borders -through what is known as the two-part Libman test. 51 What is commonly referred to as "qualified territorial application," provides for application beyond borders when: (1) there is a "real and substantial link" between Canada and the offence; and (2) if so, prosecution would not offend against "international comity." 52 Justice La Forest set out the test re: qualified territorial application in Libman v. The Queen:
As I see it, all that is necessary to make an offence subject to the jurisdiction of our courts is that a significant portion of the activities constituting that offence took place in Canada. As it is put by modern academics, it is sufficient that there be a "real and substantial link" between an offence and this country, a test well-known in public and private international law… 53 The rationale for the test is as follows: ... the criminal law is undoubtedly intended for the protection of the public, it does not do so solely by the simple expedient of directly protecting the public from harm. Rather, in conformity with its major purpose, it attempts to underline the fundamental values of our society: see the Law Reform Commission of Canada, Report 3, Our Criminal Law (1979). In doing so, it reinforces the law-abiding sentiments in society. Walsh J. in Shulman v. The King, supra, caught the essence of this when, after noting that "there is more to a...[criminal offence] than its successful culmination", he added: "Its preparation and evolution, even in the case of failure, is reprehensible". It would be a sad commentary on our law if it was limited to underlining society's values by the prosecution of minor offenders while permitting more seasoned practitioners to operate on a world-wide scale from a Canadian base by the simple manipulation of a technicality of the law's own making. What would be underlined in the public's mind by allowing criminals to go free simply because their operations have grown to international proportions, I shall not attempt to expound. 54 There is no specific criteria for applying the test. However, based on a review of the cases in which qualified territorial application has been assessed, Robert Currie has summarized the legal analysis that the court would engage in as follows:
The "real and substantial connection" inquiry is broad and requires assessment of all of the facts related to the alleged offence, including but not limited to (1) where some or all of the elements took place; (2) where the offence was initiated; (3) where the offence was prepared or formulated; (4) where harm or injury resulting from the offence occurred, including the location of the victims; or (5) where proceeds of the offence were brought. 55 On this analysis, it is plausible to suggest that there is the potential for qualified territorial application of the AHR Act in circumstances such as the following: a substantial amount of the conduct takes place in Canada; an advertisement in Canada leads to or facilitates the conduct in another country; the scheme for the conduct is devised in Canada but carried out in another country; or the benefits of the conduct will be realized in, or brought back to, Canada. 56 With respect to the trade in human eggs, it is not clear when the nexus between the conduct and Canada would be sufficient to trigger qualified territorial application of the AHR Act. Is ovarian stimulation in Canada (followed by travel to another country for egg retrieval) sufficient to trigger application of the law? Is e-mail or telephone communication from an intermediary in California to a woman in Canada seeking human eggs sufficient to trigger application of the law? Has the law been broken if a company in California arranges a contract between a couple in Canada, an egg provider in the Czech Republic, and a fertility clinic in India and the couple goes to India and receives IVF using the Czech woman's eggs? Is it legal for a Canadian company to advertise on the internet for women in India to become egg providers for reproductive purposes? Is a woman in Canada legally permitted to arrange to pay an egg bank in the U.S. to send frozen eggs to Canada for reproductive purposes? Does the following text from a U.S. clinic website describe something illegal?
Because a large proportion of CHR's [Center for Human Reproduction] patients are longdistance patients from outside the larger New York City area (both from within the United States, Canada and overseas), we know how to manage the logistics and stress of such long-distance relationships. Most of your preparatory steps will, under our supervision, be arranged at an IVF center near your home. You will have to come to New York City just once, and only for a few short days for the entire egg donor IVF cycle. 57 Based on case law, it is reasonable to conclude that there is room for some qualified territorial application of law in the context of transnational trade in human eggs. For example, a woman in Toronto ordering frozen eggs over the phone from an egg bank in Florida, providing her Canadian credit card to pay for the eggs, having them shipped to her clinic in Toronto and used to create an embryo using her partner's sperm would surely be captured by the AHR Act. How much one could amend the scenario before the nexus to Canada would become insufficient to meet the Libman test is unclear. What is clear is that some of what is currently going on meets the test.
Summary
In Canada, under s. 7 of the AHR Act, it is illegal to purchase, offer to purchase, and advertise for the purchase of eggs (and, arguably, for egg production services). Under s. 8, it is also illegal to make use of eggs for reproductive purposes in Canada unless the written consent to such use was given by the provider in accordance with the regulations (regardless of the country of origin of the eggs). Once s. 10 comes into force, it will be illegal to distribute, make use of, or import eggs (not from a spouse or partner of recipient) for reproductive purposes unless the eggs have met a series of health and safety requirements (including, notably, preservation and quarantine as well as provider screening and testing). Finally, until s. 12 comes into force, we would argue that it is illegal to reimburse expenditures (receipted or not) incurred in the course of providing eggs. Even when s. 12 is in force, legal reimbursements arguably will not include compensation for lost wages or payment for services (e.g., time, inconvenience, and discomfort) in relation to the provision of eggs.
The law as just described applies in the context of transnational trade in human eggs as long as there is a "real and substantial connection" between the violation and Canada. That is, as long as there is a sufficient nexus between the conduct (arranging for or carrying out the stimulation, retrieval, or transfer of the eggs) and Canada.
Canadian Authorities and Transnational Trade in Human Eggs
Based on the preceding two sections, we can conclude that illegal transnational trade in human eggs is (and has been) occurring. Yet there have been no charges laid or prosecutions of individuals for violations of the law. 58 This is an indefensible state of affairs that requires urgent remedial measures. Regulatory authorities should take action. First, they should complete the law by making the missing regulations and bringing the relevant sections of the Act fully into force. 59 In so doing, they should be guided by the relevant principles underlying the legislation and applied by the SCC. Second, as they are making the regulations, they should communicate very clearly and accurately with fertility service providers and recipients about the legal status of the various activities govIllegal transnational trade in human eggs is (and has been) occurring. Yet there have been no charges laid or prosecutions of individuals for violations of the law. This is an indefensible state of affairs that requires urgent remedial measures. Regulatory authorities should take action. First, they should complete the law by making the missing regulations and bringing the relevant sections of the Act fully into force. In so doing, they should be guided by the relevant principles underlying the legislation and applied by the SCC. Second, as they are making the regulations, they should communicate very clearly and accurately with fertility service providers and recipients about the legal status of the various activities governed by the law (both before and after the sections and regulations come into force). Third, they should enforce the law. Finally, they should promote national self-sufficiency.
journal of law, medicine & ethics SYMPOSIUM erned by the law (both before and after the sections and regulations come into force). Third, they should enforce the law. Finally, they should promote national self-sufficiency. The reasons for each of these steps are spelled out below.
Complete the Law
The AHR Act received Royal Assent on March 29, 2004 , at which time roughly 30 regulations were required for the law to take full effect. Following the AHRA Reference, as a result of which much of the AHR Act was found to be unconstitutional, considerably fewer regulations were and continue to be required to bring the law into effect. Since 2004, however, only one set of regulations has been made -the Consent to Use regulations for s. 8.
In explaining the lack of activity since the introduction of the AHR Act, Health Canada posted on its website the following answer to the question "Why is it taking so long to develop the regulations under the Assisted Human Reproduction Act?": Health Canada must follow the Cabinet Directive on Streamlining Regulation in developing options and recommendations for Assisted Human Reproduction. The Directive is designed to protect and advance the public interest by working with Canadians and other governments to ensure that its regulatory activities result in the greatest overall benefit to current and future generations of Canadians. The Directive includes clear requirements for the development, implementation, evaluation and review of regulations. The Government must weigh the benefits of alternatives to regulations -and of alternative regulations -against their cost, and focus resources where they can do the most good. 60 A later web posting on another part of the Health Canada website suggests a different rationale for delays in making the requisite regulations:
Out of respect for the authority of the Supreme Court of Canada in matters of constitutional law, and pending its opinion, Health Canada will not pre-publish additional regulations until the question before the Court has been resolved. Health Canada continues to develop policy in this area. 61 As regards this second explanation, it is worth noting that the SCC issued its ruling on the constitutionality of the AHR Act on December 22, 2010. Since then, Health Canada has had 18 months in which to draft missing regulations based on the work that supposedly continued unabated. With respect to the issue at hand, as at the time of writing, regulations are still required for ss. 10 and 12. Such regulations should be drafted expeditiously.
It is wrong to leave people vulnerable to the harms of unregulated trade in human eggs (whether intra or transnational) -these harms, as identified in the AHR Act, include: the commercialization and commodification of reproduction 62 and the exploitation of children, women, and men (hence, the prohibition on the sale of eggs and restrictions on reimbursements); violations of autonomy (hence, the consent requirements); and risks to human health and safety including the risk of transmission of disease (hence, the controls on distribution, use, and importation). The federal government passed the AHR Act and defended it against vigorous attack in the courts in the AHRA Reference. In turn, the SCC recognized the risks of harm as the basis for upholding the provisions of the AHR Act that were saved in the AHRA Reference. Leaving the law incomplete by not making the necessary regulations leaves children, women, and men vulnerable to the harms of unregulated trade in human eggs. Those with stewardship of the law (most notably Parliament, the Minister of Health, and Health Canada) should therefore meet their obligations through the making of regulations for ss. 10 and 12 (and in doing so be guided by the principles set out in the AHR Act and reiterated by the SCC in the AHRA Reference).
Communicate Clearly and Accurately about the Law
Over the years, there has been considerable confusion over the meaning and force of the law, particularly as it relates to s. 12 of the AHR Act -for example, whether compensation for lost wages (or time, inconvenience, and discomfort) is permitted, and whether reimbursement without receipts is permitted in the absence of the s. 12 regulations. In part, the confusion results from AHRC and Health Canada refusing to comment on the force of s. 12 It is difficult to understand why AHRC and Health Canada would have declined to publicly answer the question. Surely helping those governed by the legislation to better understand what is required for compliance with the law would be a minimum step in the direction of enforcing the legislation.
It is wrong to leave people vulnerable to the harms of uncertainty in the law. If there are harms that one is trying to prevent through legislation (as is the case in the context of the regulation of intra or transnational trade in human eggs, as explained above), then uncertainty that results in some of the harmful conduct taking place (not through intentional flouting of the law (as will be discussed below), but rather as a result of not knowing what the law permits or prohibits) is surely to be avoided.
As Health Canada moves forward with the drafting of regulations, it should communicate clearly and accurately with all interested parties. It should also be proactive and offer clear statements about the meaning and force of law where there is any indication that individuals or organizations do not properly understand the law. Past practice is not defensible and should not be allowed to continue.
Enforce the Law
According to the AHRC 2010-11 Annual Report, over the years, allegations of non-compliance with the AHR Act were investigated and dealt with:
Similar to previous years, AHRC received allegations of violations of the AHR Act, particularly with respect to the prohibitions on payment for gametes and surrogacy services. These allegations were assessed on the facts, and resolved through a transparent and standardized process in accordance with the guiding principles of the AHRC Compliance and Enforcement Policy, and in conjunction with law enforcement and disciplinary authorities where warranted. 64 Notwithstanding the above claim about transparency, we could find no official records detailing any action taken to investigate or trigger an investigation (through the AHRC, Health Canada Inspectorate, the RCMP, or any other law enforcement agency) 65 into allegations of non-compliance with ss. 7, 8, 10, or 12 of the AHR Act. 66 We do know, thanks to the efforts of an investigative journalist, however, of one official allegation of non-compliance with the AHR Act involving a Canadian provider and a Canadian clinic. Heather Cox received a $7,000 payment for eggs without providing any receipts for expenses. Her mother called to inform AHRC of the trade and AHRC passed the complaint over to the RCMP. Alison Motluk reported on this case that,
[a]ccording to records obtained through the Access to Information Act, the RCMP was already investigating the same clinic over similar allegations. Heather Cox was interviewed in a videotaped interview, she provided them with a cheque for $7,000, made out to her by CReATe and dated the day of her retrieval. (The cheque was original but had been accidentally given to her without a signature; she had already deposited the signed replacement into her account.) The RCMP also interviewed her cousin. But records show that in October 2008, the RCMP decided not to pursue the case at that time. In June, the Quebec Court of Appeal had ruled that parts of the AHR Act were unconstitutional because health is a provincial matter. The constitutional challenge did not affect the ban on purchasing eggs but did call into question the penalties. The Crown prosecutors involved in Cox's complaint felt that the case would not go forward until the Supreme Court had ruled in the matter. (As The Walrus went to press, the court had not yet rendered its decision.) 67 As Health Canada moves forward with the drafting of regulations, it should communicate clearly and accurately with all interested parties. It should also be proactive and offer clear statements about the meaning and force of law where there is any indication that individuals or organizations do not properly understand the law. Past practice is not defensible and should not be allowed to continue.
To our knowledge, no further action has been taken in this case, despite the fact that the Supreme Court of Canada decision in the AHRA Reference removed the stated obstruction to prosecution.
More recently, two other investigative journalists enquired about the enforcement of the AHR Act, this time with respect to allegations of transnational trade involving the importation of frozen eggs into Canada from the United States. They reported that according to AHRC, "The AHR Act does not regulate the import of eggs." 68 While this answer was accurate at the moment it was uttered (as the original s. 10 was struck down by the SCC in the AHRA Reference and the revised s. 10 is not yet in force), it was not true from March 29, 2004 to December 22, 2010. Prior to the AHRA Reference, s. 10 was in force and did regulate the importation of eggs for the purpose of creating an embryo. Furthermore, the statement by AHRC was not adequate, as the AHR Act, even after the AHRA Reference, regulated the purchase of eggs (regardless of whether they were sourced in Canada or abroad) and required that the consent regulations be followed even if the eggs came from another country for use in Canada. For its part, Health Canada told the reporter, "We don't have any jurisdiction over the eggs." 69 This answer, of course, failed to acknowledge that Health Canada had, and continues to have, responsibility for enforcement of the AHR Act and the AHR Act regulates the purchase of eggs for reproductive purposes as well as consent to the provision of eggs for the purpose of creating an embryo.
In sum, and quite simply, those responsible for the enforcement of the AHR Act appear to have failed to meet their obligations under the AHR Act. Even though there is law governing the practice of assisted human reproduction, the situation has been accurately described as the "Wild West." 70 Failure to enforce the law has resulted in significant disregard of, and disrespect for, the law. 71 This may lead to more people intentionally flouting the law resulting in harms that the legislation was intended to prevent. Furthermore, increasing disregard and disrespect for the law threatens our democracy and the rule of law.
Promote National Self-Sufficiency
We recognize that enforcing the AHR Act will likely reduce the supply of human eggs in Canada and could increase the demand for transnational travel to procure human eggs wholly outside Canada (to escape both the territorial and qualified territorial reach of the law). This prompts us to argue that Canadian authorities should promote national self-sufficiency in an effort to contain (if not decrease) the demand for transnational trade in human eggs. As described by Gillian Crozier and Dominique Martin, "The pursuit of self-sufficiency with respect to particular materials refers to the adoption of policies designed to achieve a supply of such materials sufficient to meet community needs using domestic resources." 72 In very general terms, national self-sufficiency is predicated upon the development and implementation of a range of policies that together would reduce the domestic demand for eggs and increase the domestic supply of eggs, thereby preventing, or at least reducing interest in, transnational trade. First, there could be a range of public health initiatives aimed at preventing and treating infertility. For example, provincial or territorial governments could enable women to avoid delaying reproduction through the introduction of sound public policies on parental leave and childcare services. In addition, provincial and territorial governments could "ensure that alternative opportunities to create families and raise children are made more readily available to all, such as adoption and fostering." 73 Second, the federal government could promote clarity regarding s. 12 of the AHR Act on reimbursement for direct, receipted expenses (including such things as travel, accommodation, and childcare and excludThose responsible for the enforcement of the AHR Act appear to have failed to meet their obligations under the AHR Act. Even though there is law governing the practice of assisted human reproduction, the situation has been accurately described as the "Wild West." Failure to enforce the law has resulted in significant disregard of, and disrespect for, the law. This may lead to more people intentionally flouting the law resulting in harms that the legislation was intended to prevent. Furthermore, increasing disregard and disrespect for the law threatens our democracy and the rule of law.
ing such things as "time, inconvenience, and discomfort associated with screening, ovarian stimulation, and oocyte retrieval." 74 ) Women who wish to gift their eggs should know what (if any) costs they may have to incur. Third, other policy initiatives (including regulatory facilitation and educational campaigns) could be introduced to promote altruistic donation of excess frozen eggs originally created for a personal reproductive project. 75 As the technology for freezing eggs improves and becomes more accessible (both physically and financially) to more women, there likely will be an increase in the number of frozen eggs that are no longer needed for their original reproductive purpose. Donating these eggs for reproductive use could increase the egg supply without risking the harms of producing eggs specifically for use by others. 76
Conclusion
The preceding arguments lead us to some very specific calls for action. First, Health Canada should immediately issue clarifying statements as regards the state of the law during the process of the making of regulations under the AHR Act. For example, at a minimum, Health Canada should make it clear that, under the AHR Act, reimbursement of actual expenditures is the only possible exception to the prohibition on payments (i.e., payments for services (sometimes described as time, inconvenience, and discomfort) and compensation for lost wages are not permitted). It should also make it clear that, as we have argued, no reimbursements are permitted until the regulations governing reimbursements are in force. Alternatively, if Health Canada disagrees with this interpretation of the law, it should explain and defend its own interpretation.
Second, Health Canada should draft the necessary regulations in a timely manner. The Minister of Health should then lay the regulations before Parliament and Parliament should refer the regulations to the appropriate committees in each House, the committees should review and report on the regulations, and the Governor in Council should make the regulations and bring the regulations and the relevant sections of the AHR Act into force.
Third, the Minister of Health should take the necessary steps to ensure the enforcement of the law to prevent or mitigate the effects of illegal transnational trade in human eggs (the commercialization and commodification of reproduction, the exploitation of children, women, and men, and risks to human health and safety including the risk of transmission of disease). 77 Fourth, the Minister of Health should work together with the Attorney General of Canada and the Attorneys General of the provinces and territories to provide guidance with respect to the qualified territorial application of the AHR Act to those who engage in transnational trade in human eggs.
Finally, in pursuit of national self-sufficiency, Health Canada should work with the provinces and territories to introduce social programs to reduce infertility and to facilitate donation of excess frozen eggs.
It is long past time for the federal government (Parliament, the Minister of Health, and Health Canada) to step up and regulate the transnational trade in human eggs in a manner consistent with the division of powers and directed by the principles of its own legislation and the values and norms of our system. We call upon the federal government to do so now.
Disclaimer
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